Skip Navigation

Rheumatology 2009 48(Supplement 3):iii1-iii2; doi:10.1093/rheumatology/kep111
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Black, C. M.
Right arrow Articles by Guillevin, L.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Black, C. M.
Right arrow Articles by Guillevin, L.
Related Collections
Right arrow Systemic Sclerosis
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Editorial

Progress in systemic sclerosis: a 10-year perspective

C. M. Black1, M. Matucci-Cerinic2 and L. Guillevin3

1Royal Free and University College Medical School, London, UK, 2Department of Biomedicine, Centre DenoThe, Division of Rheumatology, AOUC University of Florence, Florence, Italy and 3Department of Internal Medicine and Immunopathology, Hospital Cochin, Paris, France

Correspondence to: C. M. Black, Centre for Rheumatology, Hampstead Campus, Rowland Hill Street, Hampstead, London NW3 2PF, UK. E-mail: profblack@btinternet.com

The first 10% of the full text of this article appears below.

SSc is a chronic CTD that affects the skin and internal organs, and is characterized by excessive fibrosis, inflammation and vasculopathy [1–3]. The progressive occlusive vasculopathy is central to the clinical manifestations of SSc and is reflected in its characteristic complications, which include renal crisis, digital ulceration and pulmonary arterial hypertension (PAH) [4]. These . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?